172 related articles for article (PubMed ID: 24889268)
1. High throughput quantitative reverse transcription PCR assays revealing over-expression of cancer testis antigen genes in multiple myeloma stem cell-like side population cells.
Wen J; Li H; Tao W; Savoldo B; Foglesong JA; King LC; Zu Y; Chang CC
Br J Haematol; 2014 Sep; 166(5):711-9. PubMed ID: 24889268
[TBL] [Abstract][Full Text] [Related]
2. Expression of cancer-testis antigen in multiple myeloma.
He L; Ji JN; Liu SQ; Xue E; Liang Q; Ma Z
J Huazhong Univ Sci Technolog Med Sci; 2014 Apr; 34(2):181-185. PubMed ID: 24710929
[TBL] [Abstract][Full Text] [Related]
3. SSX cancer testis antigens are expressed in most multiple myeloma patients: co-expression of SSX1, 2, 4, and 5 correlates with adverse prognosis and high frequencies of SSX-positive PCs.
Taylor BJ; Reiman T; Pittman JA; Keats JJ; de Bruijn DR; Mant MJ; Belch AR; Pilarski LM
J Immunother; 2005; 28(6):564-75. PubMed ID: 16224274
[TBL] [Abstract][Full Text] [Related]
4. Cancer/Testis Antigen MAGE-C1/CT7: new target for multiple myeloma therapy.
de Carvalho F; Vettore AL; Colleoni GW
Clin Dev Immunol; 2012; 2012():257695. PubMed ID: 22481966
[TBL] [Abstract][Full Text] [Related]
5. Cancer-testis antigens: Unique cancer stem cell biomarkers and targets for cancer therapy.
Gordeeva O
Semin Cancer Biol; 2018 Dec; 53():75-89. PubMed ID: 30171980
[TBL] [Abstract][Full Text] [Related]
6. [Reseach Advances on Cancer-Testis Antigens in Multiple Myeloma -Review].
Yang ZR; Yu L; Zhu HY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Feb; 25(1):296-300. PubMed ID: 28245420
[TBL] [Abstract][Full Text] [Related]
7. Expression of cancer/testis antigens is correlated with improved survival in glioblastoma.
Freitas M; Malheiros S; Stávale JN; Biassi TP; Zamunér FT; de Souza Begnami M; Soares FA; Vettore AL
Oncotarget; 2013 Apr; 4(4):636-46. PubMed ID: 23592437
[TBL] [Abstract][Full Text] [Related]
8. Small molecule antibody targeting HLA class I inhibits myeloma cancer stem cells by repressing pluripotency-associated transcription factors.
Ikegame A; Ozaki S; Tsuji D; Harada T; Fujii S; Nakamura S; Miki H; Nakano A; Kagawa K; Takeuchi K; Abe M; Watanabe K; Hiasa M; Kimura N; Kikuchi Y; Sakamoto A; Habu K; Endo M; Itoh K; Yamada-Okabe H; Matsumoto T
Leukemia; 2012 Sep; 26(9):2124-34. PubMed ID: 22430632
[TBL] [Abstract][Full Text] [Related]
9. MAGE-C1/CT7 and MAGE-C2/CT10 are frequently expressed in multiple myeloma and can be explored in combined immunotherapy for this malignancy.
de Carvalho F; Alves VL; Braga WM; Xavier CV; Colleoni GW
Cancer Immunol Immunother; 2013 Jan; 62(1):191-5. PubMed ID: 23180015
[TBL] [Abstract][Full Text] [Related]
10. Identification of Key Genes and Pathways in Myeloma side population cells by Bioinformatics Analysis.
Yang Q; Li K; Li X; Liu J
Int J Med Sci; 2020; 17(14):2063-2076. PubMed ID: 32922167
[No Abstract] [Full Text] [Related]
11. Expression of cancer-testis antigens in stem cells: is it a potential drawback or an advantage in cancer immunotherapy.
Ghafouri-Fard S
Asian Pac J Cancer Prev; 2015; 16(7):3079-81. PubMed ID: 25854409
[TBL] [Abstract][Full Text] [Related]
12. Cancer-testis antigen expression and its epigenetic modulation in acute myeloid leukemia.
Atanackovic D; Luetkens T; Kloth B; Fuchs G; Cao Y; Hildebrandt Y; Meyer S; Bartels K; Reinhard H; Lajmi N; Hegewisch-Becker S; Schilling G; Platzbecker U; Kobbe G; Schroeder T; Bokemeyer C; Kröger N
Am J Hematol; 2011 Nov; 86(11):918-22. PubMed ID: 21898529
[TBL] [Abstract][Full Text] [Related]
13. Role of interleukin 16 in multiple myeloma.
Atanackovic D; Hildebrandt Y; Templin J; Cao Y; Keller C; Panse J; Meyer S; Reinhard H; Bartels K; Lajmi N; Sezer O; Zander AR; Marx AH; Uhlig R; Zustin J; Bokemeyer C; Kröger N
J Natl Cancer Inst; 2012 Jul; 104(13):1005-20. PubMed ID: 22745469
[TBL] [Abstract][Full Text] [Related]
14. The clinical value of the quantitative detection of four cancer-testis antigen genes in multiple myeloma.
Zhang Y; Bao L; Lu J; Liu KY; Li JL; Qin YZ; Chen H; Li LD; Kong Y; Shi HX; Lai YY; Liu YR; Jiang B; Chen SS; Huang XJ; Ruan GR
Mol Cancer; 2014 Feb; 13():25. PubMed ID: 24499297
[TBL] [Abstract][Full Text] [Related]
15. A high frequency of circulating B cells share clonotypic Ig heavy-chain VDJ rearrangements with autologous bone marrow plasma cells in multiple myeloma, as measured by single-cell and in situ reverse transcriptase-polymerase chain reaction.
Szczepek AJ; Seeberger K; Wizniak J; Mant MJ; Belch AR; Pilarski LM
Blood; 1998 Oct; 92(8):2844-55. PubMed ID: 9763569
[TBL] [Abstract][Full Text] [Related]
16. The role of Cancer/Testis Antigens in Multiple Myeloma pathogenesis and their application in disease monitoring and therapy.
Shires K; Van Wyk T
Crit Rev Oncol Hematol; 2018 Dec; 132():17-26. PubMed ID: 30447924
[TBL] [Abstract][Full Text] [Related]
17. Targeting MAGE-C1/CT7 expression increases cell sensitivity to the proteasome inhibitor bortezomib in multiple myeloma cell lines.
de Carvalho F; Costa ET; Camargo AA; Gregorio JC; Masotti C; Andrade VC; Strauss BE; Caballero OL; Atanackovic D; Colleoni GW
PLoS One; 2011; 6(11):e27707. PubMed ID: 22110734
[TBL] [Abstract][Full Text] [Related]
18. Number of expressed cancer/testis antigens identifies focal adhesion pathway genes as possible targets for multiple myeloma therapy.
Andrade VC; Vettore AL; Panepucci RA; Almeida MS; Yamamoto M; De Carvalho F; Caballero OL; Zago MA; Colleoni GW
Leuk Lymphoma; 2010 Aug; 51(8):1543-9. PubMed ID: 20528248
[TBL] [Abstract][Full Text] [Related]
19. Intratumor heterogeneity of cancer/testis antigens expression in human cutaneous melanoma is methylation-regulated and functionally reverted by 5-aza-2'-deoxycytidine.
Sigalotti L; Fratta E; Coral S; Tanzarella S; Danielli R; Colizzi F; Fonsatti E; Traversari C; Altomonte M; Maio M
Cancer Res; 2004 Dec; 64(24):9167-71. PubMed ID: 15604288
[TBL] [Abstract][Full Text] [Related]
20. Cancer-testis antigens are commonly expressed in multiple myeloma and induce systemic immunity following allogeneic stem cell transplantation.
Atanackovic D; Arfsten J; Cao Y; Gnjatic S; Schnieders F; Bartels K; Schilling G; Faltz C; Wolschke C; Dierlamm J; Ritter G; Eiermann T; Hossfeld DK; Zander AR; Jungbluth AA; Old LJ; Bokemeyer C; Kröger N
Blood; 2007 Feb; 109(3):1103-12. PubMed ID: 17023585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
